Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | |||
amphiregulin [2025/05/15 07:33] – [Clinical Relevance] administrador | amphiregulin [2025/05/15 07:33] (current) – administrador | ||
---|---|---|---|
Line 1: | Line 1: | ||
====== Amphiregulin (AREG) ====== | ====== Amphiregulin (AREG) ====== | ||
+ | |||
+ | ===== Latest PubMed-Related Articles ===== | ||
{{rss> | {{rss> | ||
+ | ---- | ||
+ | |||
+ | ---- | ||
+ | |||
Amphiregulin (AREG) is a **[[transmembrane glycoprotein]]** and a member of the **[[epidermal growth factor]] (EGF) family**. It functions primarily as a **ligand for the [[epidermal growth factor receptor]] ([[EGFR]])**. | Amphiregulin (AREG) is a **[[transmembrane glycoprotein]]** and a member of the **[[epidermal growth factor]] (EGF) family**. It functions primarily as a **ligand for the [[epidermal growth factor receptor]] ([[EGFR]])**. |